Literature DB >> 19129523

The Neurontin legacy--marketing through misinformation and manipulation.

C Seth Landefeld1, Michael A Steinman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19129523     DOI: 10.1056/NEJMp0808659

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  29 in total

1.  Hidden in plain sight marketing prescription drugs to consumers in the twentieth century.

Authors:  Jeremy A Greene; David Herzberg
Journal:  Am J Public Health       Date:  2010-03-18       Impact factor: 9.308

2.  Gabapentin and pregabalin to treat aggressivity in dementia: a systematic review and illustrative case report.

Authors:  Thitiporn Supasitthumrong; Blanca M Bolea-Alamanac; Selim Asmer; Vincent L Woo; Petal S Abdool; Simon J C Davies
Journal:  Br J Clin Pharmacol       Date:  2019-02-08       Impact factor: 4.335

3.  [Knowledge transfer between research and practice].

Authors:  C Stein
Journal:  Anaesthesist       Date:  2011-05       Impact factor: 1.041

4.  [Pain measurement in animal models].

Authors:  M Busch-Dienstfertig; C Stein
Journal:  Z Rheumatol       Date:  2013-03       Impact factor: 1.372

Review 5.  Management of painful diabetic neuropathy: guideline guidance or jungle?

Authors:  Vincenza Spallone
Journal:  Curr Diab Rep       Date:  2012-08       Impact factor: 4.810

Review 6.  Reporting bias in medical research - a narrative review.

Authors:  Natalie McGauran; Beate Wieseler; Julia Kreis; Yvonne-Beatrice Schüler; Heike Kölsch; Thomas Kaiser
Journal:  Trials       Date:  2010-04-13       Impact factor: 2.279

Review 7.  Gabapentin for chronic neuropathic pain and fibromyalgia in adults.

Authors:  R Andrew Moore; Philip J Wiffen; Sheena Derry; Thomas Toelle; Andrew S C Rice
Journal:  Cochrane Database Syst Rev       Date:  2014-04-27

8.  Risk assessment and communication tools for genotype associations with multifactorial phenotypes: the concept of "edge effect" and cultivating an ethical bridge between omics innovations and society.

Authors:  Vural Ozdemir; Guilherme Suarez-Kurtz; Raphaëlle Stenne; Andrew A Somogyi; Toshiyuki Someya; S Oğuz Kayaalp; Eugene Kolker
Journal:  OMICS       Date:  2009-02

9.  The haunting of medical journals: how ghostwriting sold "HRT".

Authors:  Adriane J Fugh-Berman
Journal:  PLoS Med       Date:  2010-09-07       Impact factor: 11.069

10.  An unbiased scientific record should be everyone's agenda.

Authors: 
Journal:  PLoS Med       Date:  2009-02-24       Impact factor: 11.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.